×
About 71,596 results

ALLMedicine Type 1 Diabetes Center

Research & Reviews  32,573 results

Impact of Flash Glucose Monitoring on Glucose Control and Hospitalizations in Type 1 Di...
https://doi.org/10.1002/dmrr.3355
Diabetes/metabolism Research and Reviews; Tsur A, Cahn A et. al.

May 28th, 2020 - We evaluated the impact of flash continuous glucose monitoring (FCGM) on glycemic control and healthcare burden in a large real-world cohort of patients with type 1 diabetes (T1D) initiating FCGM technology. In this retrospective cohort study, we ...

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro...
https://doi.org/10.1007/s40262-020-00903-0
Clinical Pharmacokinetics; Linnebjerg H, Zhang Q et. al.

May 28th, 2020 - Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the pharmacokinetics, glucodynamics, safety, and tolerabi...

Adult-onset type 1 diabetic patients with less severe clinical manifestation have less ...
https://doi.org/10.1002/dmrr.3357
Diabetes/metabolism Research and Reviews; Ren W, Yang D et. al.

May 27th, 2020 - The aim of this study was to investigate differences in clinical features and HLA genotypes between adult-onset and childhood-onset patients with type 1 diabetes in a Chinese population. This study enrolled 716 Han Chinese patients with type 1 dia...

Association between age at type 1 diabetes diagnosis and metabolic outcome at young adu...
https://doi.org/10.1002/dmrr.3356
Diabetes/metabolism Research and Reviews; Goldberg T, Brener A et. al.

May 27th, 2020 - Younger age at diagnosis of type 1 diabetes (T1D) may affect the clinical course and outcome. We examined whether age at diagnosis was associated with glycemic control and metabolic outcome in young adulthood. This observational study included 105...

Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients.
https://doi.org/10.1080/08037051.2020.1770054
Blood Pressure; Błaszkowska M, Shalimova A et. al.

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

see more →

Guidelines  149 results

Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated R...
https://doi.org/10.1213/ANE.0000000000004491
Anesthesia and Analgesia; Martin LD, Hoagland MA et. al.

Nov 6th, 2019 - Approximately 1 of every 300 children in the United States has type 1 diabetes mellitus (T1D), and these patients may require anesthetics for a variety of procedures. Perioperative coordination is complex, and attention to perioperative fasting, a...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

Transcultural Diabetes Care in the United States
https://journals.aace.com/doi/pdf/10.4158/PS-2019-0080

May 7th, 2019 - The American Association of Clinical Endocrinologists (AACE) has created a transculturalized diabetes chronic disease care model that is adapted for patients across a spectrum of ethnicities and cultures. AACE has conducted several transcultural a...

Reprogramming Cells to Make Insulin
https://academic.oup.com/jes/article/3/6/1214/5476582
Journal of Endocrine Society;

Apr 23rd, 2019 - Type 1 diabetes is a disease characterized by the destruction of insulin-secreting β-cells in the pancreas. Individuals are treated for this disease with lifelong insulin replacement. However, one attractive treatment possibility is to reprogram a...

see more →

Drugs  639 results see all →

Clinicaltrials.gov  35,435 results

Impact of Flash Glucose Monitoring on Glucose Control and Hospitalizations in Type 1 Di...
https://doi.org/10.1002/dmrr.3355
Diabetes/metabolism Research and Reviews; Tsur A, Cahn A et. al.

May 28th, 2020 - We evaluated the impact of flash continuous glucose monitoring (FCGM) on glycemic control and healthcare burden in a large real-world cohort of patients with type 1 diabetes (T1D) initiating FCGM technology. In this retrospective cohort study, we ...

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro...
https://doi.org/10.1007/s40262-020-00903-0
Clinical Pharmacokinetics; Linnebjerg H, Zhang Q et. al.

May 28th, 2020 - Ultra rapid lispro (URLi) is a novel insulin lispro formulation developed to more closely match physiological insulin secretion and improve postprandial glucose control. This study compared the pharmacokinetics, glucodynamics, safety, and tolerabi...

Adult-onset type 1 diabetic patients with less severe clinical manifestation have less ...
https://doi.org/10.1002/dmrr.3357
Diabetes/metabolism Research and Reviews; Ren W, Yang D et. al.

May 27th, 2020 - The aim of this study was to investigate differences in clinical features and HLA genotypes between adult-onset and childhood-onset patients with type 1 diabetes in a Chinese population. This study enrolled 716 Han Chinese patients with type 1 dia...

Association between age at type 1 diabetes diagnosis and metabolic outcome at young adu...
https://doi.org/10.1002/dmrr.3356
Diabetes/metabolism Research and Reviews; Goldberg T, Brener A et. al.

May 27th, 2020 - Younger age at diagnosis of type 1 diabetes (T1D) may affect the clinical course and outcome. We examined whether age at diagnosis was associated with glycemic control and metabolic outcome in young adulthood. This observational study included 105...

Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients.
https://doi.org/10.1080/08037051.2020.1770054
Blood Pressure; Błaszkowska M, Shalimova A et. al.

May 27th, 2020 - Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM).Results: Although chronic complications resulting from hyperglycemia, in particular macro...

see more →

News  2,757 results

Deep Dive Quantifies Risk of COVID-19 Death in Both Diabetes Types
https://www.medscape.com/viewarticle/930856

May 19th, 2020 - The risk of death from COVID-19 is significantly increased in people with both main types of diabetes, although this is strongly influenced by age, as well as A1c and obesity, new pre-print data from the UK show. The findings — which have not yet ...

A Silver Lining to the Pandemic as 'Tele-Diabetes' Here to Stay
https://www.medscape.com/viewarticle/930743

May 18th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The rapid escalation of telemedicine due to COVID-19 is likely to shift paradigms in the way type 1 diabetes care is delivered in the future, rega...

Be Vigilant for Signs of Diabetes During COVID-19 Lockdown
https://www.medscape.com/viewarticle/929243

Apr 22nd, 2020 - As concerns about coronavirus deter people from seeking hospital care, endocrinologists and a leading UK charity are calling for general practitioners (GPs) and the public to be aware of the signs and symptoms of type 1 diabetes. Diabetes UK say t...

Use of Diabetes Technology Is Lower Among Black, Hispanic Patients
https://www.medscape.com/viewarticle/928587

Apr 12th, 2020 - A retrospective study of patients at a minority-serving, safety-net hospital showed low uptake of diabetes technology among black patients with type 1 diabetes, compared with their white counterparts. The researchers also found lower usage of the ...

Asthma, Type 1 Diabetes Often Co-occur in Children, Families
https://www.medscape.com/viewarticle/927488

Mar 24th, 2020 - Asthma and type 1 diabetes often co-occur in individual children and their family members, new research suggests. Siblings with either condition were at increased risk for the other compared with the general population. However, although individua...

see more →

Patient Education  43 results see all →